Medpace Holdings (MEDP) EBT Margin (2015 - 2026)
Medpace Holdings' (MEDP) quarterly EBT Margin came in at 21.44% in Q2 2026, up 80.0% YoY from 11.91% in Q2 2025, and up 2.65% on a QoQ basis from 20.89% in Q1 2026.
Medpace Holdings (MEDP) EBT Margin (2015 - 2026) Analysis & Trends
Medpace Holdings (MEDP) has 12 years of EBT Margin data on file, last reported at 21.44% in Q2 2026.
- Quarterly EBT Margin rose 80.0% year-over-year to 21.44% in Q2 2026, while the trailing twelve-month figure through Jun 2026 was 21.53% (down 67.0% YoY) and the FY2025 annual result came in at 21.44%, down 113.0% from the prior year.
- EBT Margin grew to 21.44% in Q2 2026, from 20.89% in the prior quarter.
- In the past five years, EBT Margin ranged from a high of 24.95% in Q4 2024 to a low of 16.44% in Q2 2023.
- A 5-year average of 20.38% and a median of 20.9% in 2024 frame the typical range for EBT Margin.
- Annual changes were most pronounced in 2023 — EBT Margin slumped 445 bps — and 2024, when it surged 675 bps.
- Tracing MEDP's EBT Margin over 5 years: stood at 18.69% in 2022, then fell by 3 bps to 18.2% in 2023, then soared by 37 bps to 24.95% in 2024, then fell by 11 bps to 22.14% in 2025, then fell by 3 bps to 21.44% in 2026.
- The last three EBT Margin figures came in at 21.44% (Q2 2026), 20.89% (Q1 2026), and 22.14% (Q4 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 213.88 Bn | 209.81 Bn | 8.34 Bn | 16.04% |
| 2 | Danaher | 140.65 Bn | 136.30 Bn | 3.61 Bn | 17.21% |
| 3 | Idexx Laboratories | 46.02 Bn | 45.83 Bn | 779.09 Mn | 34.29% |
| 4 | Agilent Technologies | 39.85 Bn | 38.05 Bn | 990.00 Mn | 22.23% |
| 5 | Iqvia Holdings | 39.20 Bn | 37.12 Bn | 1.44 Bn | 6.89% |
| 6 | Natera | 38.80 Bn | 37.70 Bn | 696.04 Mn | -12.17% |
| 7 | Illumina | 30.11 Bn | 28.94 Bn | 770.00 Mn | 22.43% |
| 8 | Mettler Toledo International | 28.66 Bn | 28.61 Bn | 650.22 Mn | 28.17% |
| 9 | Quest Diagnostics | 26.24 Bn | 25.61 Bn | 1.03 Bn | 13.54% |
| 10 | Medpace Holdings | 16.54 Bn | 16.03 Bn | 201.64 Mn | 21.44% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 21.44% |
| Mar 31, 2026 | 20.89% |
| Dec 31, 2025 | 22.14% |
| Sep 30, 2025 | 21.64% |
| Jun 30, 2025 | 20.64% |
| Mar 31, 2025 | 21.16% |
| Dec 31, 2024 | 24.95% |
| Sep 30, 2024 | 22.27% |
| Jun 30, 2024 | 20.92% |
| Mar 31, 2024 | 22.07% |
| Dec 31, 2023 | 18.20% |
| Sep 30, 2023 | 16.89% |
| Jun 30, 2023 | 16.44% |
| Mar 31, 2023 | 19.82% |
| Dec 31, 2022 | 18.69% |
| Sep 30, 2022 | 21.34% |
| Jun 30, 2022 | 17.65% |
| Mar 31, 2022 | 19.74% |
| Dec 31, 2021 | 18.12% |
| Sep 30, 2021 | 18.52% |